AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2016
Dec 27, 2016
3174_iss_2016-12-27_93a24c1e-80d0-4923-b643-af096456d87f.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Östersjöstiftelsen
Instrument
| Instrument | Shares SE0003613090 | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given Data not given |
|
| Voting rights | ||
| Transaction | ||
| Reason for major shareholding notification Share loan | ||
| Date | 22/12/2016 | |
| Limit for number of shares | 10 % | |
| Limit for number of votes | 10 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 2,274,179 | |
| Directly held voting rights | 2,274,179 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 13.06 % | |
| Directly held voting rights | 13.06 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 13.06 % | 2,274,179 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, |
||
| first paragraph, line 3 - Physically settled - Cash settled |
||
| Total | 13.06 % | 2,274,179 |
| Group total holdings | ||
| Voting rights 2,274,179 Percentage of voting rights 13.06 |
||
| Notes (other relevant informations according to law) Återlämning av aktielån |
||
| Published 27/12/2016 10:10 |
||
| Contact |
Name Mattias Klintemar Phone 08-6085156 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13